fb-pixel

Harvard study finds pandemic will cost primary care doctors an average of $65,000

Its authors say some medical practices could be at risk of closing down.

Boston Children’s Hospital was just ranked best of its kind in the nation — again

For the seventh year in a row, Boston Children’s Hospital has claimed the No. 1 spot in an annual ranking of the best children’s hospitals in the country.

The world needs Covid-19 vaccines. It may also be overestimating their power

The world might in the not-too-distant future get vaccines against Covid-19. But those vaccines won’t necessarily prevent all or even most infections.

A cancer patient reconsiders her end-of-life wishes amid Covid-19

Diagnosed with lung cancer, she had signed a do-not-resuscitate order. The coronavirus pandemic made her reconsider her end-of-life wishes.

Covid-19′s future: small outbreaks, monster wave, or ongoing crisis
Three scenarios for the future of Covid-19 differ on details, but all foresee a world that looks and feels nothing like the world of just three months ago.

In a medical first, doctors treat Parkinson’s with a novel brain cell transplant
If successful, the surgery could change Parkinson’s disease from an inexorable, cruel, and sometimes fatal decline to — for at least some patients — a condition that can be successfully treated.

Latest Headlines in Healthcare

The race to save lives

“I’m nervous about reopening”

The Globe has enlisted three medical workers to tell their stories in their own words. Throughout the coming days, you’ll meet a top emergency room doctor at Massachusetts General Hospital, a young critical care nurse at Tufts Medical Center, and a respiratory therapist at Newton Wellesley Hospital. All have opened up to Globe reporters about their patients and their experiences.

An hour on the COVID ICU overnight shift

Bianca Dintino's overnight shift as the COVID ICU charge nurse is a steady stream of patient alarms and PPE quick changes at Tufts Medical Center May 4.

Infect volunteers with Covid-19? A proposal lays bare a minefield of issues

The idea of controlled human infection trials has been met with enthusiasm in some quarters, and reservations in others, including from some who run them.

Experts question Facebook’s approach to combat Covid-19 misinformation

Facebook's Covid-19 misinformation campaign pulls from several psychology studies. The authors and outside experts worry Facebook missed the message.

Covid-19 has shuttered labs. It could put a generation of researchers at risk

The pandemic has left scientists across the country scrambling to save their work — and has left others grieving the loss of experiments.

Gilead coronavirus drug may exceed $2 billion in sales

At $4,500 for a round of treatment for coronavirus, remdesivir, Gilead Sciences Inc.’s new medicine, could be reasonably priced and still generate over $2 billion in revenue for the biotech, according to analysts at Piper Sandler.

Mass. General physician: 'We've definitely hit the plateau of coronavirus here'

Dr. Ali Raja says the ER waiting room at Massachusetts General Hospital is empty in his latest installment for "The race to save lives" project.

Coronavirus ICU nurse dons PPE before her shift

Bianca Dintino dons personal protective equipment (PPE) before her shift on the coronavirus intensive care unit at Tufts Medical Center Friday April 24.